drugset
drugset / Trial / NCT04969068

The Median Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP With Alfentanil 10µg/kg

NCT04969068 ↗

Phase 4 Unknown 50 enrolled Tianjin Nankai Hospital
NaSequentialOpen-labelOther

Summary

Remimazolam has shown promising results for sedation in colonoscopy . Alfentanil is widely used in the analgesia of ERCP . The purpose of the study was to determine the median effective dose of remimazolam for duodenoscopy insertion during ERCP with alfentanil 10µg/kg.

Timeline

Start
2021-07-23
Primary completion
2021-12-30
Completion
2021-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Remimazolam Small molecule 0.2 mg/kg Intravenous

Indications

No indication recorded.